Furthermore, squamous cell carcinoma is commonly a byproduct of mutations in TP53, cyclin dependent kinase inhibitor 2A (CDKN2A), SOX2, and akt serine/thereonine kinase (AKT) [41]. The gene discussed is CDKN2A; the disease is squamous cell carcinoma.